Thermo Fisher Scientific (TMO) Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell

Go back to Thermo Fisher Scientific (TMO) Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell

Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.32, Revenues Beat

October 21, 2020 6:02 AM EDT

Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.63, $1.32 better than the analyst estimate of $4.31. Revenue for the quarter came in at $8.52 billion versus the consensus estimate of $7.65 billion.

Third Quarter 2020 Highlights

Third quarter revenue increased 36% to $8.52 billion.Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.Third quarter adjusted EPS increased 91% to $5.63.Generated $2.0 billion of COVID-19 related revenue in the quarter and returned the base business to growth.Further expanded our global pandemic response, including launching the Amplitude Solution to automate high-throughput PCR-based testing, adding... More